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In the print version of the aforementioned article, Table 2 listing genes regulated by high glucose or high glucose plus
FOXO1 is incomplete due to an oversight during compilation of the ﬁnal data. The correct Table 2 appears below. The
online version reﬂects these changes.
TABLE 2
Genes regulated by high glucose or high glucose plus FOXO1 siRNA in RMECs
Gene
Unique
identiﬁcation
High glucose
High glucose plus
FOXO1 siRNA
Mean Median Mean Median
Endothelial cell inﬂammation/activation
CCL2 Rn.4772 2.2 1.7 0.4 0.3
CCL5 Rn.8019 2.1 2.1 0.1 0.1
CXCL1 Rn.10907 2.8 2.5 0.3 0.2
ICAM1 Rn0.12 2.3 2.0 0.4 0.4
IL6 Rn.9873 2.4 2.0 0.3 0.3
IL7 Rn.10793 2.3 1.7 0.3 0.2
VCAM1 Rn.11267 2.8 2.0 0.3 0.3
ANXA5 Rn.3318 1.6 1.6 0.6 0.6
CCL20 Rn.10722 2.4 1.6 0.3 0.3
CPB2 Rn.12572 1.9 1.2 0.5 0.6
CSF2 Rn.44285 1.4 1.2 0.3 0.2
ICAM2 Rn.138519 3.0 1.1 0.2 0.2
INOS Rn.10400 1.9 1.3 0.4 0.5
SEL-E Rn.10359 1.7 1.0 0.4 0.3
SEL-L Rn.10461 1.8 1.1 0.3 0.3
SEL-P Rn.10012 2.0 1.2 0.3 0.3
TGFB1 Rn.40136 2.6 1.5 0.3 0.2
TGFB2 Rn.24539 2.3 1.5 0.3 0.2
VWF Rn.35561 1.7 1.1 0.4 0.3
IL11 Rn.47218 1.4 0.7 0.3 0.5
IL15 Rn.2490 2.0 1.1 0.2 0.2
IL3 Rn.10652 1.0 0.5 0.3 0.6
Endothelial cell apoptosis
BAX Rn.10668 2.5 2.0 0.5 0.5
BCL2 Rn.9996 2.5 2.1 0.4 0.4
CASP3 Rn.10562 2.9 2.4 0.5 0.5
CASP6 Rn.88160 4.1 4.2 0.3 0.3
CASP8 Rn.54474 2.0 1.9 0.5 0.5
TNFRSF11B Rn.9792 1.7 1.7 0.3 0.4
TNFRSF10B Rn.105558 2.6 1.5 0.3 0.4
BCL2A1 Rn.19770 1.7 1.7 0.7 0.7
BIRC3 Rn.64578 1.8 1.7 0.7 0.7
BIRC4 Rn.91239 2.8 1.7 0.7 0.8
Angiogenesis
ITGB1 Rn.25733 2.6 2.0 0.3 0.3
ANGPT1 Rn.120272 4.9 4.6 0.4 0.4
FLT4 Rn.81043 3.5 2.7 0.2 0.2
VEGFA Rn.1923 3.0 2.8 0.4 0.3
ITGA5 Rn.100796 2.8 1.1 0.4 0.4
ITGB3 Rn.17129 2.4 1.4 0.3 0.3
KDR Rn.88869 1.9 1.1 0.4 0.4
MMP2 Rn.6422 2.5 1.6 0.4 0.4
MMP9 Rn.10209 2.1 1.3 0.3 0.4
TEK Rn.9159 3.9 1.6 0.3 0.3
COL18A1 Rn.12030 2.2 1.3 0.5 0.5
PLG Rn.20178 1.7 1.1 0.5 0.6
Data are mean and median of three independent arrays for each time point. Boldface indicates that both the mean and median of the
experimental group was 1.7- or 0.58-fold of the corresponding control (high glucose versus low glucose; high glucose plus FOXO1 siRNA
versus high glucose plus scrambled siRNA). RMECs were incubated with or without high glucose (25 mmol/l) for 5 days. Some cells were
transfected with FOXO1 siRNA or scrambled siRNA for 24 h prior to incubation in high glucose for 5 days. Total RNA was isolated and
subjected to focused microarray analysis. The table lists genes differentially regulated by high glucose or FOXO1 siRNA in high-glucose–
treated microvascular endothelial cells. High glucose: fold change in mRNA level in high-glucose–treated cells versus standard-glucose–
treated cells. High glucose plus FOXO1 siRNA: fold change in mRNA level of each gene in cells transfected with FOXO1 siRNA plus high
glucose versus scrambled siRNA plus high glucose.
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